Is Phenylpropanolamina [INN-Spanish] Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Phenylpropanolamina [INN-Spanish]? Is Phenylpropanolamina [INN-Spanish] safe for nursing mother and child? Does Phenylpropanolamina [INN-Spanish] extracts into breast milk? Does Phenylpropanolamina [INN-Spanish] has any long term or short term side effects on infants? Can Phenylpropanolamina [INN-Spanish] influence milk supply or can Phenylpropanolamina [INN-Spanish] decrease milk supply in lactating mothers?

• DrLact safety Score for Phenylpropanolamina [INN-Spanish] is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of Phenylpropanolamina [INN-Spanish] may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that Phenylpropanolamina [INN-Spanish] may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using Phenylpropanolamina [INN-Spanish] .
• It is recommended to evaluate the advantage of not breastfeeding while using Phenylpropanolamina [INN-Spanish] Vs not using Phenylpropanolamina [INN-Spanish] And continue breastfeeding.
• While using Phenylpropanolamina [INN-Spanish] Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Appears as part of many compounds for cough relief, mucolytics, expectorants and nose decongestants. Single drug (one active principle only) medicines should be preferred mostly while breastfeeding. On latest update relevant data on breastfeeding was not found. Pharmacokinetic data indicates that drug excretion into breast milk may occur. Withheld from marketing in many countries because of hypertension and severe side effects.